Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
751.00    12.50 (1.69%)
Bid:
748.00
Ask:
751.00
Spread: 3.00 (0.401%)
Market Cap: £855.69m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Trading Update

25 Jan 2016 07:00

RNS Number : 7891M
Fevertree Drinks PLC
25 January 2016
 

25th January 2016

 

Fevertree Drinks plc ("Fever-Tree")

 

Trading update

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, today announces its trading update for the year ended 31 December 2015.

 

The Board is pleased to announce that Fever-Tree has performed strongly in the second half of 2015. It is anticipated that sales in the second half will be ahead of the prior year period by 77%. Full year revenue is expected to be circa £59.2 million, reflecting growth of 71% on 2014.

 

Sales in the UK performed exceptionally well in the second half of 2015 and full year revenue is expected to be circa 84% ahead of 2014. Sales performance has been strong in both the On-Trade and Off-Trade channels, with notable growth achieved over the Christmas period against strong comparatives from 2014.

 

In the USA, the momentum seen in the first half continued during the second half of 2015 and as a result full year revenue is expected to be circa 65% ahead of 2014.

 

The strong sales growth in the Rest of Europe achieved in the first half accelerated in the second half of 2015 and it is anticipated that full year revenue will be circa 66% ahead of 2014.

 

Rest of World sales growth in the second half of 2015 remained strong and full year revenue is expected to be circa 50% ahead of 2014.

 

Over the period, Fever-Tree's free cash flow generation and balance sheet have remained strong. Year-end net cash position is anticipated to be in line with Board expectations, with significant cash balances still to collect given the strength of trading over the Christmas period.

 

FY15 expectations

 

Given the strong sales in the final two months of the year, the Board anticipates that the outcome for the full year will be comfortably ahead of its expectations.

 

Fever-Tree will announce its Preliminary Results on 14 March 2016.

 

Commenting on today's announcement, Tim Warrillow, CEO of Fever-Tree said:

 

"We are encouraged to report another positive trading statement. Fever-Tree continues to trade strongly, buoyed by a festive period significantly ahead of last year. We have continued to widen and deepen our penetration with growth across our product range in all our regions. We remain well positioned in our markets and look forward to the future with confidence."

 

UK Financial Reporting Notification

The Group's consolidated financial statements are prepared in accordance with IFRS as adopted by the EU. However, the accounting framework used for the Fevertree Drinks plc individual company accounts has been UK GAAP up to 31 December 2014. For the year ended 31 December 2015, the company is required by FRS 100 "Application of Financial reporting Requirements" to change its accounting framework. The Group intends to apply FRS 101 "Reduced Disclosure Framework" to the company accounts for the year ended 31 December 2015, which is not expected to give rise to any significant changes in disclosures. Shareholders holding more than 5% of the allotted shares of the company are entitled to object to the adoption of FRS 101. Objections should be made to the Company's registered office by 28 February 2016.

 

The Group's consolidated financial statements are unaffected by this change, and will continue to be prepared in accordance with IFRS as adopted by the EU.

 

 

For further information:

 

Fevertree Drinks plc

c/o FTI +44 (0)20 3727 1000

Tim Warrillow, Co-founder and CEO

Charles Rolls, Co-founder and Executive Deputy Chairman

Andy Branchflower, Finance Director

FTI Consulting - Financial PR

+44 (0)20 3727 1000

Jonathon Brill

fever-tree@fticonsulting.com

Oliver Winters

Tom Hufton

Investec Bank plc - Nominated Adviser and Broker

+44 (0)20 7597 4000

Garry Levin

Symmie Swill

Matt Lewis

David Anderson

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 50 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). Approximately 70 per cent of the Group's sales were derived from outside of the UK in financial year 2015, with key overseas markets in the US and Europe.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFERLDIFFIR
Date   Source Headline
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSCommencement of share buyback programme
10th Feb 20251:35 pmRNSHolding(s) in Company
7th Feb 20254:35 pmRNSHolding(s) in Company
7th Feb 20254:07 pmRNSHolding(s) in Company
7th Feb 20254:05 pmRNSHolding(s) in Company - correction
6th Feb 202511:39 amRNSHolding(s) in Company
5th Feb 20255:39 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSCompletion of Share Issuance to Molson Coors
3rd Feb 202512:20 pmRNSStandard form for notification of major holdings
30th Jan 20253:01 pmRNSDirector/PDMR Shareholding
30th Jan 20257:02 amRNSUS Strategic Partnership with Molson Coors
20th Jan 20257:00 amRNSAppointment Of Corporate Broker
6th Jan 20252:15 pmRNSStandard form for notification of major holdings
2nd Dec 202411:47 amRNSStandard form for notification of major holdings
2nd Dec 20247:00 amRNSBlock Listing Return
2nd Dec 20247:00 amRNSTotal Voting Rights
28th Nov 20245:12 pmRNSStandard form for notification of major holdings
18th Sep 20242:42 pmRNSStandard form for notification of major holdings
12th Sep 20247:00 amRNSFY24 Interim Results to 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
6th Jun 20241:29 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Trading Statement
3rd Jun 20247:00 amRNSBlock Listing Return
3rd Jun 20247:00 amRNSTotal Voting Rights
9th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSGrant of Options
1st May 20247:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSBlock Admission Application
18th Jan 20242:30 pmRNSAdmission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.